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Abstract
Introduction—Opioid withdrawal syndrome is a critical component of opioid abuse and consists
of a wide array of symptoms including increases in pain sensitivity (hyperalgesia). A reliable
preclinical model of hyperalgesia during opioid withdrawal is needed to evaluate possible
interventions to alleviate withdrawal. The following study describes a method for assessing
increases in thermal sensitivity on the hotplate in a mouse model of spontaneous morphine
withdrawal.
Methods—C57BL/6J mice received 5.5 days of 30, 56, or 100 mg/kg morphine or saline (s.c.,
twice daily). In Experiment I, thermal sensitivity data were collected at baseline and at 8, 24, 32,
48 hrs and 1 week following the final injection. Thermal sensitivity was assessed by examining
latency to respond on a hotplate across a range of temperatures (50, 52, 54, and 56°C). In
Experiment II, 0.01 mg/kg buprenorphine was administered 30 min prior to each testing session
during the withdrawal period. In Experiment III, jumping during a 30 min period was assessed at
baseline and at 0, 8, 24, 32, and 48 hrs following the final morphine injection.
Results—During the withdrawal period, thermal sensitivity increased significantly in all
morphine-treated mice as compared to saline-treated mice. Thermal sensitivity was greater in mice
treated with 56 mg/kg morphine compared to 30 mg/kg and peaked earlier than in mice treated
with 100 mg/kg (32 hrs v 1 wk). The increase in thermal sensitivity following 56 mg/kg morphine
was attenuated by a dose of buprenorphine that did not produce antinociception alone (i.e., 0.01
mg/kg). In general, the results of the jumping experiment paralleled those obtained in Experiment
I.
Discussion—Response latency on the hotplate is a reliable and sensitive measure of
spontaneous morphine withdrawal in mice, making it an ideal behavior for assessing the potential
of medications and environmental interventions to alleviate opioid withdrawal.
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The opioid withdrawal syndrome consists of a constellation of symptoms that appear
following the termination of a prolonged period of opioid administration. The presence or
desire to avoid these symptoms may even contribute to continued drug taking (Le Moal and
Koob, 2007). As such, withdrawal is a critical component of opioid abuse. One of the many
symptoms that make up the Clinical Opiate Withdrawal Scale or COWS (Tompkins et al.,
2009) is an increase in pain or sensitivity to pain. An increase in pain sensitivity or
hyperalgesia during spontaneous withdrawal occurs in pain patients in experimental settings
(Lipman and Blumenkopf, 1989) and is reported in case studies, as well (Devulder et al.,
1996). Healthy human subjects show hyperalgesia during both spontaneous (Angst et al
2003) and antagonist precipitated withdrawal (Compton et al., 2003; Sun, 1998).
The development of pharmacological and environmental interventions to mitigate
hyperalgesia during opioid withdrawal requires reliable preclinical models of this symptom
of withdrawal. In 1973, Tilson et al. reported that sensitivity to electric foot shock increases
following the cessation of morphine in rats. Since then a modest number of papers have
described hyperalgesia in animal models of opioid withdrawal. In rats, hyperalgesia occurs
during both precipitated as well as spontaneous morphine withdrawal and is observed with
multiple pain assays: hotplate, tail flick, and shock discrimination (Devillers et al., 1995;
Dunbar and Pulai 1998; Grilly and Gowans 1986; Jin et al., 2012; Li et al., 2001; Tilson et
al., 1973). Hyperalgesia in rats also occurs during withdrawal from fentanyl (Laulin et al.,
2002) and heroin (Devillers et al., 1995; Laulin et al., 1998). Beyond rodents, withdrawal
hypersensitivity is seen in both dogs (Martin et al., 1987) and cats (Johnson and Duggan,
1981).
Traditionally, opioid withdrawal in mice is measured by the presence of behavioral signs
such as jumping, wet dog shakes, piloerection, diarrhea, and ptosis (e.g. Kest et al., 2002;
Papaleo and Contarino 2006). To the best of our knowledge only two studies from
laboratories other than our own employ a hyperalgesia model for examining opioid
withdrawal in mice. These studies examine only a single time point during spontaneous
withdrawal (Rubovich et al., 2009) or employ a precipitated, rather than a spontaneous,
withdrawal procedure (Crane and Shen 2007).
The current study describes a new method for assessing hyperalgesia in a mouse model of
spontaneous morphine withdrawal. We hypothesize that thermal sensitivity on a hotplate
will increase during spontaneous withdrawal from a range of morphine does. Further, we
hypothesize that buprenorphine treatment during the withdrawal period will attenuate the
increase in sensitivity. Buprenorphine, a low efficacy mu agonist, was selected because it is
commonly used in agonist replacement therapy for opioid dependence (e.g. Connock et al.
2007 and Kraus et al., 2011), and used to suppress spontaneous opioid withdrawal
symptoms during the induction phase of treatment (Strain et al. 2011).
2. METHODS
2.1 Animals
All experiments were conducted in male C57BL/6J mice (Jackson Labs, Raleigh, NC), 10
weeks of age upon delivery. Male C57BL/6J mice were selected to allow comparison with
other data collected in our laboratory regarding morphine’s pharmacological effects as well
as the extensive literature on the behavioral effects of opioids in C57BL/6 mice.
Additionally, in comparison to other inbred strains, C57BL/6J mice are known to be highly
sensitive across many behavioral assays. Specifically, they exhibit high sensitivity in
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measures of acute nociception (Mogil et al., 2000), naloxone precipitated morphine
withdrawal (Kest et al. 2002) and morphine self-administration (Elmer et al. 2009).
Mice were individually housed in polycarbonate cages (floor area=335cm2) with continuous
access to food and water throughout the study. The colony room was maintained on a 12-hr,
reverse, light/dark cycle (lights off at 7:00 am) and all behavioral testing was conducted
during the dark cycle, between 9:00 am and 7:00 pm. Mice were habituated to handling and
the colony room environment for two weeks prior to any experimental manipulation. Mice
were also exposed to the testing environment for at least two days prior to initiation of an
experiment and for 1 hr prior to all behavioral testing. Although a criterion was set such that
mice <20 g or those that lost >20% of initial body weight would be removed from the study,
it was not necessary to remove any mice from the study. Animal protocols were approved by
the Institutional Animal Care and Use Committee, and the methods were in accord with the
“Guide for the Care and Use of Laboratory Animals” (Institute of Laboratory Animal
Research, Commission on Life Sciences, National Research Council, 2011).
2.2 Experimental Procedures
Thermal Sensitivity—Thermal sensitivity was assessed using a hot plate analgesia meter
(25.3 × 25.3 cm), Columbus Instruments, Columbus, OH. During each 1-hr hot plate testing
period, a temperature-effect curve was determined for each mouse. Sensitivity was evaluated
by recording the latency to lick or flutter the hind paw(s), or to jump from the hot plate
surface at each of four temperatures presented in the following order: 50, 54, 52, 56°C with
15-min intervals between temperatures. Response latency was measured to the nearest 0.1
sec. To prevent tissue damage, a predetermined cutoff time of 20 sec was defined as the
maximal trial duration. Immediately following the termination of a trial, whether due to a
mouse’s response or elapsed cutoff time, mice were removed from the hot plate surface.
Parameters were selected based on prior work in our laboratory regarding responses on the
hot plate (e.g. Fischer et al. 2008; Balter and Dykstra, 2012).
Jumping—To measure jumping, mice were removed from their home cages and placed in
a 4L beaker in the center of a Med Associates Inc. activity chamber. Vertical beam breaks,
monitored by a computer, were used to count the number of jumps that occurred in a 30-min
period.
Pharmacological Procedure—During the saline/morphine administration period, doses
of saline, 30 mg/kg, 56 mg/kg or 100 mg/kg of morphine were administered daily for 5.5
days, with injections occurring at 10:00 am and 8:00 pm daily (11 injections total).
Morphine sulfate and buprenorphine hydrochloride, provided by the National Institute on
Drug Abuse (Bethesda, MD, USA), were both dissolved in 0.9% saline to yield all
concentrations. Doses were injected subcutaneously at a volume of 0.1 ml/10 g.
2.3 Experimental Design
Experiment 1: Thermal sensitivity following saline, 30, 56, or 100 mg/kg of
morphine—On day one, thermal sensitivity was assessed in all four groups of mice (n=8)
at 10:00 am (baseline 1) and at 6:00 pm (baseline 2). A 2-way repeated measures ANOVA
revealed no difference between baseline 1 and baseline 2; therefore, baselines were averaged
for all analyses and figures. At 10:00 am on day two 30, 56, 100 mg/kg morphine or saline
administration began as described above and continued for 5.5 days. Following the last dose
of morphine on day seven, thermal sensitivity was assessed six more times: immediately
after the final injection (10:00 am on day 7), at 8 hrs (6:00 pm on day 7), at 24 hrs (10:00 am
on day 8), at 32 hrs (6:00 pm on day 8), at 48 hrs (10:00 am on day 9) and at 1 week (10:00
am on day 14). This period (days 7–14) was designated as the withdrawal period.
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Experiment 2: Buprenorphine and thermal sensitivity—In order to select a dose of
buprenorphine that did not produce antinociception on its own, a cumulative dose effect
curve (0.01 to 0.32 mg/kg) was obtained for buprenorphine at each of the four temperatures
tested during the thermal sensitivity assessment (50, 52, 54 and 56 ±0.1°C). Baseline
response latencies on the hot plate were determined twice prior to the beginning of the
buprenorphine dose effect curve and spaced 30 min apart. Data from these baselines were
averaged to yield one baseline value. Following baseline determination, responding on the
hot plate was examined over multiple cycles, and doses of buprenorphine were spaced 30
min apart. Drugs were administered at the start of each cycle and latency on the hot place
was determined during the last minute of the cycle. Drug doses were increased cumulatively,
with the dose increasing in one-half log unit increments prior to each cycle (0.01, 0.03, 0.1,
0.32 mg/kg). Buprenorphine effects were expressed as a percentage of the maximal possible
effect (% MPE) using the following formula:
During the withdrawal experiment, on day one thermal sensitivity was assessed in two
groups of mice (n=8) at 10:00 am (baseline 1) and 6:00 pm (baseline 2). A 2-way repeated
measures ANOVA revealed no difference between baseline 1 and baseline 2; therefore,
baselines were averaged for all analyses and figures. At 10:00 am on day two 56 mg/kg
morphine administration began for all mice as described above and continued for 5.5 days.
Following the last dose of morphine on day seven, thermal sensitivity was assessed five
more times: immediately after the final injection (10:00 am on day 7), at 8 hrs (6:00 pm on
day 7), at 24 hrs (10:00 am on day 8), at 32 hrs (6:00 pm on day 8), and at 48 hrs (10:00 am
on day 9). A dose of 0.01 mg/kg buprenorphine or saline was administered subcutaneously
30 minutes prior to each testing session on days 7–9. This period (days 7–9) was designated
as the withdrawal period.
Experiment 3: Jumping responses following saline, 30, 56, or 100 mg/kg of
morphine—On day one, jumping was assessed in all four groups of mice (n=8) at 10:00
am (baseline 1, AM) and at 6:00 pm (baseline 1, PM). One week later on day 8, a second
baseline measure (baseline 2, AM and PM) was taken at 10:00 am and 6:00 pm. The second
set of baselines (10:00 am and 6:00 pm on day 8) was used for data analysis. At 10:00 am on
day nine 30, 56, 100 mg/kg morphine or saline administration began as described above and
continued for 5.5 days. Following the last dose of morphine on day 14, thermal sensitivity
was assessed five more times: immediately after the final injection (10:00am on day 14), at
8 hrs (6:00 pm on day 14), at 24 hrs (10:00 am on day 15), at 32 hrs (6:00 pm on day 15), at
48 hrs (10:00 am on day 16). This period (days 14–16) was designated as the withdrawal
period.
2.4 Data analysis
All data are presented as means (±SEM). In Experiments I and II, response latencies were
used to derive a measure of thermal sensitivity, designated as ET10. The ET10 represents
the theoretical temperature required to produce a response latency of 10 sec (half the
maximal response latency of 20 sec) and was derived using log-linear interpolation. In
Experiment III, jumping responses during the withdrawal period are presented and analyzed
as jumps during the withdrawal period minus the average number of jumps that occurred
during the corresponding baseline period (i.e., Since data for the 0, 24, and 48 hrs
withdrawal period fell in the AM, baseline measures from the morning period were used.
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Likewise since data for the 8 and 36 hrs withdrawal period fell in the PM, baseline measures
from the evening period were used.)
Analysis of the latency data used a 3-way repeated measures ANOVA with time and
temperature as repeated measures factors and group as an independent factor. ET10 and
jumping data were analyzed using a 2-way repeated measures ANOVA with time as the
repeated measures factor and group as an independent factor. For the 2- and 3-way
ANOVA, an alpha level of significance was set at p<0.01. Following the 3-way ANOVA,
appropriate follow-up contrasts and Student’s t-tests were performed using a fully saturated
mixed model of the data. The model was a straight model of the means and included random
intercepts for each mouse. Following the 2-way ANOVAs, appropriate follow-up contrasts
were performed using a model of jumps or ET10 as a function of time and group. The null
hypothesis assumed no mean difference in the number of jumps or the ET10 values.
Standard error was adjusted for multiple observations within each mouse.
Statistical analyses were conducted with an alpha level of significance set at p<0.001. The
alpha level was determined using Bonferoni corrections to account for the large number of
comparisons. The ANOVA’s were performed using SPSS for Windows software, version
9.0. All post hoc analysis was performed using SAS for Windows software, version 9.2.
Figures were created with GraphPad Prism 5.
3. Results
3.1 Thermal sensitivity following spontaneous withdrawal from 30, 56, or 100 mg/kg
morphine
Fig. 1 shows the latency to respond on the hot plate as a function of temperature at baseline,
8, 24, 32, 48 hrs and 1 wk following termination of the 5.5 day treatment period of either 30,
56, or 100 mg/kg morphine or saline. In general, two findings were consistent across all time
points. First, latency to respond on the hot plate decreased as a function of temperature.
Response latencies in both saline and morphine-treated mice were at or close to the maximal
value of 20 sec when the hot plate was set at 50°C; at 52, 54 and 56°C, latencies averaged
12.8, 9.4 and 5.7 sec, respectively. Second, response latencies at the 0 (data not shown), 8,
24, 32 and 48-hr and 1 wk time points for saline-treated mice were never significantly
different from baseline, calculated as the average of baseline 1 and 2, indicating that
repetition of testing did not produce measurable effects on response latency. In addition,
immediately following the final morphine injection (0 hr), response latencies were at the cut
off value of 20 sec at all temperatures for morphine-treated mice; consequently these data
are not shown. The failure to respond within in the 20 sec maximal trial duration indicates a
full antinociceptive response to acute morphine exposure.
A 3-way repeated measures ANOVA revealed main effects of time and temperature F(5,
135) = 33.483, p<0.001 and F(3, 81)=1332.942, p<0.001, respectively. Follow up Student’s
t-tests were then used to compare individual groups, time points, and temperatures.
In general, the curves obtained in the morphine-treated mice were displaced downward from
those obtained at baseline and from those of saline-treated mice. Significant differences in
response latencies were apparent between morphine-treated and saline- treated mice
throughout the withdrawal period. Significant differences between the 30 mg/kg morphine-
and saline-treated mice were apparent at 32 and 48 hrs (52oC) t621= 3.87, 4.43, p<0.001,
respectively. Significant differences between the 56 mg/kg morphine- and saline-treated
mice were apparent at 8 hrs (52°C) t621= 3.41, p<0.001; 24 hrs (52 and 54°C) t621= 6.13,
5.25, p<0.001; 32 hrs (50, 52, 54°C) t621=6.12, 4.96, 5.13, p<0.001; 48 hrs (50, 52, 54°C)
t621=3.65, 6.787, 3.82, p<0.001; and at 1 wk (50 and 54°C) t621=3.45, 3.55, p<0.001.
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Significant differences between the 100 mg/kg morphine- and saline-treated mice were
apparent at 48 hrs (50 and 52°C) t621= 4.30, 5.21, p<0.001 and at 1 wk (50, 52, 54°C) t621=
6.51, 5.85, 4.37, p<0.001. In addition, the responses of morphine-treated mice were
significantly different from baseline at all point where responses were different from those
of saline-treated mice. These differences suggest that mice treated with 30, 56, or 100 mg/kg
of morphine for 5.5 days and then withdrawn from morphine were more sensitive to the
thermal stimulus than mice treated with saline.
It is also important to note significant differences in response latency between different
morphine treated groups during the withdrawal period. Response latencies of mice treated
with 56 mg/kg morphine were significantly different from those of mice treated with 30 mg/
kg morphine at 8hrs and 24hrs (52°C) t621=3.31, 3.70, p<0.001, respectively and at 32 hrs
(50°C) t621=5.32, p<0.001. Response latencies in mice treated with 56 mg/kg morphine
were also significantly different from response latencies obtained mice treated with 100 mg/
kg morphine at 8hrs and 24hrs (52°C) t621=4.08, 3.44, p<0.001, respectively and at 32 hrs
(50°C) t621=4.43, p<0.001. Finally, a significant difference in response latencies was
apparent between mice treated with 100 mg/kg and 30 mg/kg morphine at 1 wk (50 and
52°C) t621=5.66, 4.02, p<0.001.
Taken together, these data suggest that 5.5 days of morphine treatment was sufficient to
produce significant changes in thermal sensitivity compared to both within-subject baselines
and saline controls. However, the dose of morphine (30, 56, or 100 mg/kg) affected the
extent and time course of this response, with the greatest changes in latency observed
following 56 mg/kg morphine and at 32 hrs into the withdrawal period.
Fig. 2 shows the ET10 value at baseline, 8, 24, 32, 48 hrs and 1 wk following termination of
the 5.5-day treatment period with either 30, 56, 100 mg/kg morphine or saline. The ET10
values were derived from the data shown in fig. 1. They represent the theoretical
temperature necessary to produce a 10 sec response on the hotplate. A two-way repeated
measures ANOVA revealed a main effect of time F(5, 135) = 2.299, p<0.05. Individual
groups and time points were compared using appropriate follow up contrasts. For mice
treated with 30 mg/kg morphine, a significant difference in ET10 value compared to
baseline was apparent at 32 and 48 hrs, t133=3.42, 4.30, p<0.001, respectively. For mice
treated with 56 mg/kg morphine, a significant difference in ET10 value compared to
baseline was apparent at 24, 32, 48 hrs and 1 wk, t133=5.45, 6.74, 4.97, 3.97, p<0.001,
respectively. At each of these time points (24, 32, 48 hrs and 1 wk), the ET10 values of mice
treated with 56 mg/kg morphine were also significantly different from those of saline-treated
mice, t133=4.46, 5.37, 3.91, 3.52, p<0.001, respectively. For mice treated with 100 mg/kg
morphine, a significant difference in ET10 value compared to baseline was apparent at 32,
48 hrs and 1 wk, t133=3.64, 6.89, 8.29, p<0.001, respectively. The ET10 values of mice
treated with 100 mg/kg morphine were also significantly different from those of saline-
treated mice at 48 hrs and 1 wk, t133=5.16, 6.75, p<0.001, respectively. There were no
significant differences between the ET10 values of the groups at baseline or between the
ET10 values of saline-treated mice across time. Taken together, these data further support
the hypothesis that 5.5 days of morphine treatment significantly increase thermal sensitivity
during spontaneous morphine withdrawal.
3.2 Effects of buprenorphine on thermal sensitivity during spontaneous morphine
withdrawal
Buprenorphine is a partial mu-opioid receptor agonist and, like all mu-opioid agonists, it
produces antinociception on the hotplate. Consequently, prior to determining whether
buprenorphine would attenuate withdrawal induced increases in thermal sensitivity, a dose
of buprenorphine that did not produce antinociception on its own was identified.
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Fig. 3a presents the dose effect curve of buprenorphine (0.01 mg/kg–0.32 mg/kg) at each of
the temperatures used during the thermal sensitivity testing. Based on these data, a dose of
0.01 mg/kg buprenorphine was selected since this dose did not produce measurable
antinociception on the hotplate at 50, 52, 54 or 56°C
Fig. 3b shows the ET10 value at baseline, 8, 24, 32, and 48 hrs following termination of 5.5
days of twice daily morphine. As in Experiment I, ET10 values represent the theoretical
temperature necessary to produce a 10 sec response on the hotplate. All mice in this
experiment received 56 mg/kg morphine. During the withdrawal period, mice received
saline or 0.01 mg/kg buprenorphine treatment 30 min prior to test sessions at 8, 24, 32 and
48 hrs. Immediately following the final morphine injection (0 hr), response latencies were at
the cut off value of 20 sec at all temperatures; consequently these data are not shown.
A two-way repeated measures ANOVA revealed a main effect of time as well as a time x
group interaction F(4, 56) = 11.978, 3.739, p<0.01, respectively. Individual groups and time
points were compared using appropriate follow up contrasts. Significant differences were
apparent between the buprenorphine-treated and saline- treated groups at 24 and 32 hours,
t56=3.94, 3.56, p<0.001, respectively. Additionally, response latencies of buprenorphine-
treated mice showed no difference from baseline through out the withdrawal period
(p>0.01). However, significant differences were again apparent between the saline-treated
group and baseline at all withdrawal time points (8, 24, 32, and 48 hrs), t56=3.66, 6.35, 6.65,
3.74, p<0.001. These data suggest that buprenorphine can attenuate the decrease in response
latency observed during morphine withdrawal.
3.3 Jumping behavior during spontaneous withdrawal from 30, 56, or 100 mg/kg morphine
Experiment III assessed jumping responses during a 30-min period at baselines and at 0, 8,
24, 32, and 48 hrs following termination of the 5.5 day treatment period with either 30, 56,
100 mg/kg morphine or saline (s.c., twice daily). Jumping responses provide a measure of
withdrawal for comparison to the thermal sensitivity data.
Fig. 4 shows the number of jumps obtained at the morning (10:00 am) and evening (6:00
pm) baselines. Jumping responses during the withdrawal period are presented and analyzed
as jumps observed during the withdrawal period minus the average number of jumps that
occurred during the corresponding baseline period (i.e., 0, 24, and 48 hrs minus AM
baseline; 8 and 36 hrs minus PM baseline). This adjustment for AM and PM baseline
measures was included since baseline differences were observed at the two time periods.
A two-way repeated measures ANOVA revealed a main effect of time as well as a time x
group interaction F(4, 108) = 19.57, 2.87, p<0.01, respectively. Individual groups and time
points were compared using appropriate follow up contrasts. Significant differences in
adjusted jumping between mice treated with 56 mg/kg morphine and saline were apparent at
24, 32 and 48 hrs, t108= 5.81, 3.61, 3.66, p<0.001, respectively. A significant difference was
seen in adjusted jumping between mice treated with 100 mg/kg morphine and saline at 24
hrs, t108= 4.43, p<0.001. In addition, immediately following the final morphine injection (0
hr), no jumping was observed in any of the morphine treated mice.
Taken together, these data suggest that 5.5 days of morphine is sufficient to produce
significant changes in jumping behavior compared to saline controls. However, as seen in
Experiment I, the extent of this response varies with the dose of morphine (30, 56, or 100
mg/kg), with the greatest effects observed following 56 mg/kg.
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The experiments yielded three main findings. First, the results from Experiment I supported
the hypothesis that the measurement of changes in thermal sensitivity provides a reliable
method for assessing spontaneous withdrawal from morphine in mice. Second, Experiment
II demonstrated that buprenorphine could attenuate changes in thermal sensitivity as
measured by latency to respond on the hotplate. Third, the results from Experiment III
indicated that changes in thermal sensitivity during withdrawal were similar to changes in
jumping behavior, a well-established measure of morphine withdrawal. Taken together,
these data validate the thermal sensitivity procedure as a method for assessing spontaneous
morphine withdrawal.
In the first experiment, an orderly temperature by latency relationship was observed at all
time points, with increasing temperatures producing shorter response latencies. Treatment
with all three of the morphine doses (30, 56, or 100 mg/kg) produced significant decreases
in response latency on the hotplate following the cessation of morphine treatment. The
downward displacement of the temperature-response curves was most prominent at 52 and
54°C. At 56°C, response times were so short that changes in response time were difficult to
detect. The response latencies of saline-treated control groups were consistent across all time
points. This illustrates that neither 1) repeated testing nor 2) time of day measurably affected
responding on the hotplate. Finally, across all experimental groups there was little within-
group variability as measured by standard error. The observation that mice were more
sensitive to a thermal stimulus during morphine withdrawal is consistent with previous
research in both humans and animals reporting heightened sensitivity to thermal stimuli
following termination of a regimen of morphine administration (Angst et al. 2003; Compton
et al. 2003; Dunbar and Pulaj 1998; Rubovitch et al. 2009; Sweitzer et al. 2004).
The effect of dose and the time course of withdrawal are clearly apparent in the ET10 data,
where a single latency score was generated for each time point. It is well established that
dose of morphine is a factor in the severity of physical dependence (e.g., Papaleo and
Contarino, 2006). In the experiment reported here, looking at the totality of the week-long
withdrawal period, treatment with 56 mg/kg morphine produced a more pronounced
increase in sensitivity than 30 mg/kg morphine; however, the time course during which the
behavior was expressed was similar following both 30 and 56 mg/kg. For both groups,
thermal sensitivity peaked in the second day following the cessation of morphine
administration and showed a return toward baseline levels by one week.
The magnitude of the change in ET10 value in mice treated with 100 mg/kg morphine was
similar to that of mice treated with 56 mg/kg; however, the time course of this decrease was
shifted temporally. We speculate that treatment with 100 mg/kg morphine produced a more
severe withdrawal syndrome and that a change in thermal sensitivity was only apparent as
physical dependence eased during the spontaneous withdrawal period. It is possible that
other symptoms of withdrawal such as sedation blocked the measurement of increases in
thermal sensitivity or that this behavior is only apparent at a certain magnitude of
withdrawal severity. Taken together, these data suggest that a change in latency to respond
on the hotplate is a sensitive measure of morphine withdrawal; however, time, dose and
hotplate temperature are all critical variables to consider when using this measure.
The second experiment demonstrated that changes in thermal sensitivity during withdrawal
could be attenuated by treatment with buprenorphine. Buprenorphine was selected because it
is commonly used in agonist replacement therapy for opioid dependence (Kraus et al.,
2011). Mice received either saline or a non-antinociceptive dose (0.01 mg/kg) of
buprenorphine during the withdrawal period, following the cessation of 5.5 days of 56 mg/
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kg morphine. The response latency of buprenorphine-treated mice was attenuated compared
to saline-treated mice at 24 and 32 hrs. Mice that received saline during the withdrawal
period showed the same course of withdrawal as mice similarly treated with 56mg/kg
morphine in Experiment I.
Experiment III examined jumping behavior as a measure of withdrawal severity. Jumping
was selected for comparison because it is a well-established measure of opioid withdrawal
(eg. Saelens et al., 1971; Kest et al., 2002; and Papaleo and Contarino, 2006). In the current
experiment, withdrawal severity, as measured by number of jumps in a 30-min period
replicated the findings of the thermal sensitivity experiments. Termination of treatment with
56 mg/kg morphine produced the most pronounced increase in jumping compared to
treatment with 30 mg/kg or 100 mg/kg morphine. Experiment III revealed two major
limitations of using jumping to assess withdrawal severity. First, baseline data indicate that
time of testing (early or late in the dark-cycle) can affect responding. Second, within-group
variability for the jumping response is relatively large. As a result, it is more difficult to
determine whether differences between experimental groups are significant when jumping is
used to measure withdrawal.
The most notable limitation of the thermal sensitivity procedure examined here is the
difficulty in automating the measure since it is time intensive and requires observers who are
well trained in the observation of hotplate responses. Nevertheless, the thermal sensitivity
procedure could be adjusted for higher throughput screening by examining latencies at a
single temperature (52°C) and a single time point (24 or 32 hrs). Additionally, the procedure
could be adapted for within subject (baseline v withdrawal period) or between subject
(treatment group v untreated withdrawal group) designs.
In summary, the present study supports the use of thermal sensitivity, as measured by
changes in response latency on the hotplate, as a reliable method for assessing spontaneous
morphine withdrawal in mice. Response latencies on the hotplate show little variability
within groups and little effect of repeated testing, maximizing sensitivity to subtle changes
in withdrawal severity. The procedure is also well suited for examining withdrawal over
longer periods, a distinct advantage over procedures in which withdrawal is precipitated by
an antagonist and withdrawal behaviors are observed at a single time point. These
characteristics make the thermal sensitivity procedure optimal for assessing the efficacy of
medications and environmental interventions for alleviating opioid withdrawal. In fact, our
laboratory recently showed that two environmental interventions, i.e., access to a running
wheel and group housing, could attenuate the increase in thermal sensitivity observed during
spontaneous withdrawal from morphine (Balter and Dykstra, 2012).
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Fig 1. Effects of 30, 56 or 100 mg/kg morphine or saline treatment on latency (mean ±SEM) to
respond on the hotplate at 50, 52, 54, and 56° C
Morphine or saline treatment consisted of 5.5 days of twice daily injections (s.c.). Latency
on the hotplate was determined at baseline and at 8, 24, 32, 48 hrs, and 1 wk after the final
injection. Abscissa: hotplate temperature in ° C. Ordinate: latency to respond in seconds.
N=7–8. Statistically significant differences (p<0.001) are indicated as follows: A= 30 mg/kg
v. sal, B= 56 mg/kg v sal, C= 100 mg/kg v sal, X= 56 mg/kg v 30 and 100 mg/kg, Y= 100
mg/kg v 30 mg/kg.
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Fig. 2. ET10 values (mean ±SEM) for mice following 5.5 days of 30, 56 or 100 mg/kg morphine
or saline treatment
ET10 values represent the temperature that would produce a 10 sec response on the hotplate.
Response latency on the hotplate was determined at baseline and at 8, 24, 32, 48 hrs and 1
wk after the final injection. N=8. Statistically significant differences are indicated as
follows: *= a difference from the group’s baseline, # = a difference between morphine and
saline treated mice at a particular time point. p<0.001
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Fig. 3. The effect of 0.01 mg/kg buprenorphine on withdrawal from 5.5 days of 56 mg/kg
morphine
A. Dose effect curves for buprenorphine (0.01– 0.32 mg/kg) at 50, 52, 54, and 56°C. Mean
latencies (±SEM) are presented as % maximum possible effect (%MPE). B. ET10 values
(mean ±SEM) for mice treated with 0.01 mg/kg buprenorphine or saline following 5.5 days
of 56 mg/kg morphine. ET10 values represent the temperature that would produce a 10 sec
response on the hotplate. Response latency on the hotplate was determined at baseline and at
8, 24, 32, and 48 hrs after the final morphine injection. Mice received 0.01 mg/kg
buprenorphine (s.c.) 30 min prior to each hotplate test session. N=8. Statistically significant
differences are indicated as follows: *= a difference from the group’s baseline, # = a
difference between buprenorphine and saline treated mice. p<0.001
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Fig. 4. Jumps (mean ±SEM) adjusted for baseline following 30, 56 or 100 mg/kg morphine or
saline
Morphine or saline treatment consisted of 5.5 days of twice daily injections (s.c.). Jumping
was determined at baseline and at 0, 8, 24, 32, and 48 hrs after the final injection. Baseline
jumps indicate total jumping in 30 min at 10am and 6pm. Jumps at 0, 8, 24, 32, and 48 hrs
indicate jumps observed during the 30-min withdrawal period minus the average number of
jumps that occurred during the corresponding baseline period. Data obtained for the 0, 24,
and 48 hrs withdrawal period fell in the AM; therefore, total jumps were adjusted using
baseline measures from the AM period. Data obtained for the 8 and 36 hrs withdrawal
period fell in the PM; therefore, total jumps were adjusting using baseline measures from the
PM period. N=8. * = a statistically significant difference compared to saline treated mice.
p<0.001.
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